NCT02711449View on ClinicalTrials.gov

Preoperative Methylprednisolone to Patients Suspected of Appendicitis Undergoing Laparoscopy

PHASE2CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Suspected Appendicitis
Interventions
DRUG

Methylprednisolone

125 mg methylprednisolone as an intravenously bolus injection approximately 30 minutes prior to skin incision.

DRUG

0.9% Saline

0,9% Saline as an intravenously bolus injection approximately 30 minutes prior to skin incision.

Trial Locations (2)

Unknown

Nordsjaellands Hospital, Hillerød

Køge Sygehus, Køge

All Listed Sponsors
collaborator

Zealand University Hospital

OTHER

lead

Jakob Kleif

OTHER

NCT02711449 - Preoperative Methylprednisolone to Patients Suspected of Appendicitis Undergoing Laparoscopy | Biotech Hunter | Biotech Hunter